Bevacizumab/Capecitabine Regimen

Preferred Label : Bevacizumab/Capecitabine Regimen;

NCIt synonyms : Xeloda/Avastin Regimen; Xeloda-Avastin Regimen; Capecitabine/Bevacizumab; Capecitabine-Bevacizumab; Capecitabine-Bevacizumab Regimen; Bevacizumab/Capecitabine; Bevacizumab-Capecitabine; Capecitabine/Bevacizumab Regimen; Avastin-Xeloda;

NCIt related terms : Capecitabine and Bevacizumab; Capecitabine and Bevacizumab-bvzr; Capecitabine and Bevacizumab-aybi; Capecitabine and Bevacizumab-equi; Capecitabine and Bevacizumab-awwb; Capecitabine and Bevacizumab-adcd; Capecitabine and Bevacizumab-maly; Capecitabine and Bevacizumab-onbe;

NCIt definition : A regimen consisting of bevacizumab and capecitabine that may be used for the treatment of colorectal cancer, small bowel , ampullary and appendiceal adenocarcinoma.;

NCI Metathesaurus CUI : CL523554;

Codes from synonyms : 7214; 127300; 127522; 127226; 127448; 127152; 127374; 127596;

Details

Origin ID

C136243;

UMLS CUI

C4526517;

Est indiqué pour
- Breast cancer metastatic [MedDRA Preferred Term]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bevacizumab [NCIt concept]
- Capecitabine [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Colorectal Carcinoma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients